These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 28345188)
21. The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae. Lewis DA Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv47-51. PubMed ID: 24243880 [TBL] [Abstract][Full Text] [Related]
22. Time trends in positive gonorrhoea diagnoses at the Christchurch Sexual Health Service (2012-2022): a data audit study. Denison HJ; Creighton J; Douwes J; Coshall M; Young H Sex Health; 2024 Jun; 21():. PubMed ID: 38935836 [TBL] [Abstract][Full Text] [Related]
23. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia. Hustig A; Bell C; Waddell R Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709 [TBL] [Abstract][Full Text] [Related]
24. Susceptibility pattern of Neisseria gonorrhoeae isolated at the Komfo, Anokye Teaching Hospital, Ghana to commonly prescribed antimicrobial agents. Addy PA East Afr Med J; 1994 Jun; 71(6):368-72. PubMed ID: 7835257 [TBL] [Abstract][Full Text] [Related]
25. Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome. Manavi K; Zafar F; Shahid H Int J STD AIDS; 2010 Feb; 21(2):138-40. PubMed ID: 19884359 [TBL] [Abstract][Full Text] [Related]
26. Unintended consequences: the potential impacts of the British Association for Sexual Health and HIV (BASHH) 2019 gonorrhoea guidelines. Burton R; Duncan S; Wardle E; Patel C; Clarke E Int J STD AIDS; 2021 Mar; 32(4):344-351. PubMed ID: 33345746 [TBL] [Abstract][Full Text] [Related]
27. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea]. Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358 [TBL] [Abstract][Full Text] [Related]
28. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
29. Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011. Lechtenberg RJ; Samuel MC; Bernstein KT; Lahiff M; Olson N; Bauer HM Sex Transm Dis; 2014 May; 41(5):338-44. PubMed ID: 24722391 [TBL] [Abstract][Full Text] [Related]
30. No way back for quinolones in the treatment of gonorrhoea. Goold PC; Bignell CJ Sex Transm Infect; 2006 Jun; 82(3):225-6. PubMed ID: 16731673 [TBL] [Abstract][Full Text] [Related]
31. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines. Farhi D; Hotz C; Poupet H; Gerhardt P; Morand P; Poyart C; Sednaoui P; Avril MF; Dupin N Acta Derm Venereol; 2009; 89(5):484-7. PubMed ID: 19734973 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins. Regnath T; Mertes T; Ignatius R Euro Surveill; 2016 Sep; 21(36):. PubMed ID: 27632642 [TBL] [Abstract][Full Text] [Related]
33. A systematic review and appraisal of the quality of practice guidelines for the management of Dickson C; Arnason T; Friedman DS; Metz G; Grimshaw JM Sex Transm Infect; 2017 Nov; 93(7):487-492. PubMed ID: 28360378 [TBL] [Abstract][Full Text] [Related]
34. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010. Lahra MM; Commun Dis Intell Q Rep; 2012 Mar; 36(1):95-100. PubMed ID: 23153085 [TBL] [Abstract][Full Text] [Related]
35. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda. Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585 [TBL] [Abstract][Full Text] [Related]
36. Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations. Forsyth S; Penney P; Rooney G Int J STD AIDS; 2011 May; 22(5):296-7. PubMed ID: 21571983 [TBL] [Abstract][Full Text] [Related]
37. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target? Tuddenham S; Ghanem KG Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778 [No Abstract] [Full Text] [Related]
38. Gonorrhoea treatment guideline compliance and influence factors in Guangdong province, China: a cross-sectional survey. Xiong M; Zhao P; Wu X; Huang S; Yang M; Wang C; Zheng H BMJ Open; 2024 Jul; 14(7):e084731. PubMed ID: 39067888 [TBL] [Abstract][Full Text] [Related]
39. ECDC public health response to the threat of resistant gonorrhoea in Europe. Van de Laar M Euro Surveill; 2012 Jun; 17(24):. PubMed ID: 22720771 [No Abstract] [Full Text] [Related]
40. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]